These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38387256)

  • 1. Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD).
    Herrera MC; Johnson J; Lim S; Morales KH; Wilson JD; Hadland SE; Metzger D; Wood S; Dowshen N
    Drug Alcohol Depend; 2024 Apr; 257():111132. PubMed ID: 38387256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Qualitative Study of Barriers and Facilitators to Integrating Medications for Opioid Use Disorder and HIV Preexposure Prophylaxis for Adolescents and Young Adults.
    Herrera MC; Darien K; Wood S; Hadland SE; Metzger D; Dowshen N
    J Addict Med; 2023 Nov-Dec 01; 17(6):e349-e354. PubMed ID: 37934522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.
    Eger WH; Altice FL; Lee J; Vlahov D; Khati A; Osborne S; Wickersham JA; Bohonnon T; Powell L; Shrestha R
    Harm Reduct J; 2022 Oct; 19(1):120. PubMed ID: 36307817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
    McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
    Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of HIV pre-exposure prophylaxis in adolescents and young adults: Barriers and opportunities.
    Mocorro I; Sandhu PJ; Rowniak S; Leonard A
    J Am Assoc Nurse Pract; 2020 Aug; 33(9):700-708. PubMed ID: 32804806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
    PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Goyal S; Monsour M; Ko JY; Curtis KM; Whiteman MK; Coy KC; Cox S; Romero L
    Contraception; 2023 Jan; 117():67-72. PubMed ID: 36243128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare Payment for Opioid Treatment Programs.
    Nakamoto CH; Huskamp HA; Donohue JM; Barnett ML; Gordon AJ; Mehrotra A
    JAMA Health Forum; 2024 Jul; 5(7):e241907. PubMed ID: 39028654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute HIV Diagnosis After Initiation of Pre-exposure Prophylaxis in a Young Adult Patient: A Case Report.
    Warus J; Hidalgo MA; Belzer M; Olson-Kennedy J
    J Adolesc Health; 2024 Jan; 74(1):205-207. PubMed ID: 37690011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Preexposure Prophylaxis Care Continuum Among Individuals Receiving Medication for Opioid Use Disorder, South Carolina, 2020-2021.
    Johnson J; Gormley MA; Bentley S; Baldwin C; Bublitz M; Heavner SF; Roth P; Litwin AH
    Am J Public Health; 2022 Jan; 112(1):34-37. PubMed ID: 34936400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015-2018.
    Barocas JA; Gai MJ; Nurani A; Bagley SM; Hadland SE
    AIDS Care; 2023 Mar; 35(3):431-436. PubMed ID: 35468009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012-2017.
    Huang YA; Tao G; Smith DK; Hoover KW
    Clin Infect Dis; 2021 Feb; 72(3):379-385. PubMed ID: 33527117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System.
    Hojilla JC; Hurley LB; Marcus JL; Silverberg MJ; Skarbinski J; Satre DD; Volk JE
    JAMA Netw Open; 2021 Aug; 4(8):e2122692. PubMed ID: 34436609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder.
    Beck L; Parlier-Ahmad AB; Martin CE
    J Subst Abuse Treat; 2022 Jan; 132():108506. PubMed ID: 34098202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.
    Watson DL; Shaw PA; Petsis DT; Pickel J; Bauermeister JA; Frank I; Wood SM; Gross R
    J Int AIDS Soc; 2022 Feb; 25(2):e25867. PubMed ID: 35192740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
    Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
    J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.